Why 503B SKNV 1 STATEMENT OF THE ALLIANCE FOR PHARMACY COMPOUNDING: UNDERSTANDING LAW AND REGULATION GOVERNING THE COMPOUNDING OF PEPTIDE PROD The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step A new FDA advisory panel meeting, influenced by RFK Jr.'s push for broader access, will weigh the potential benefits and risks of widely promoted peptides. Click the link in bio to read BPC 157: What It Is, What We Know, and Why Its Use for Arthritis Remains Unproven San Diego Orthobiologics Medical Group 503A vs. 503B Epicur Pharma